Working… Menu

CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03914651
Recruitment Status : Recruiting
First Posted : April 15, 2019
Last Update Posted : May 14, 2019
Information provided by (Responsible Party):
Reproductive & Genetic Hospital of CITIC-Xiangya

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 30, 2020
Estimated Study Completion Date : April 30, 2021